BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 17329272)

  • 1. Limited fluoroquinolone resistance among Mycobacterium tuberculosis isolates from Rwanda: results of a national survey.
    Umubyeyi AN; Rigouts L; Shamputa IC; Fissette K; Elkrim Y; de Rijk PW; Struelens MJ; Portaels F
    J Antimicrob Chemother; 2007 May; 59(5):1031-3. PubMed ID: 17329272
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Low levels of second-line drug resistance among multidrug-resistant Mycobacterium tuberculosis isolates from Rwanda.
    Umubyeyi A; Rigouts L; Shamputa IC; Dediste A; Struelens M; Portaels F
    Int J Infect Dis; 2008 Mar; 12(2):152-6. PubMed ID: 17950021
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of trends of ofloxacin resistance in Mycobacterium tuberculosis.
    Verma JS; Nair D; Rawat D; Manzoor N
    Indian J Med Microbiol; 2011; 29(3):280-2. PubMed ID: 21860110
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fluoroquinolone susceptibility among Mycobacterium tuberculosis isolates from the United States and Canada.
    Bozeman L; Burman W; Metchock B; Welch L; Weiner M;
    Clin Infect Dis; 2005 Feb; 40(3):386-91. PubMed ID: 15668861
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Trends in fluoroquinolone resistance of Mycobacterium tuberculosis complex in a Taiwanese medical centre: 1995-2003.
    Huang TS; Kunin CM; Shin-Jung Lee S; Chen YS; Tu HZ; Liu YC
    J Antimicrob Chemother; 2005 Dec; 56(6):1058-62. PubMed ID: 16204341
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Surveillance of Mycobacterium tuberculosis susceptibility to second-line drugs in Hong Kong, 1995-2002, after the implementation of DOTS-plus.
    Kam KM; Yip CW
    Int J Tuberc Lung Dis; 2004 Jun; 8(6):760-6. PubMed ID: 15182147
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Surveillance of drug-resistant tuberculosis in the state of Gujarat, India.
    Ramachandran R; Nalini S; Chandrasekar V; Dave PV; Sanghvi AS; Wares F; Paramasivan CN; Narayanan PR; Sahu S; Parmar M; Chadha S; Dewan P; Chauhan LS
    Int J Tuberc Lung Dis; 2009 Sep; 13(9):1154-60. PubMed ID: 19723407
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Results of a national survey on drug resistance among pulmonary tuberculosis patients in Rwanda.
    Umubyeyi AN; Vandebriel G; Gasana M; Basinga P; Zawadi JP; Gatabazi J; Pauwels P; Nzabintwali F; Nyiramasarabwe L; Fissette K; Rigouts L; Struelens MJ; Portaels F
    Int J Tuberc Lung Dis; 2007 Feb; 11(2):189-94. PubMed ID: 17263290
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Drug resistance profiles of Mycobacterium tuberculosis isolates: five years' experience and insight into treatment strategies for MDR-TB in Lima, Peru.
    Timperi R; Han LL; Sloutsky A; Becerra MC; Nardell EA; Salazar JJ; Smith-Fawzi MC
    Int J Tuberc Lung Dis; 2005 Feb; 9(2):175-80. PubMed ID: 15732737
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Fluoroquinolone resistance in Mycobacterium tuberculosis isolates: associated genetic mutations and relationship to antimicrobial exposure.
    Wang JY; Lee LN; Lai HC; Wang SK; Jan IS; Yu CJ; Hsueh PR; Yang PC
    J Antimicrob Chemother; 2007 May; 59(5):860-5. PubMed ID: 17412727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fluoroquinolone resistance detection in Mycobacterium tuberculosis with locked nucleic acid probe real-time PCR.
    van Doorn HR; An DD; de Jong MD; Lan NT; Hoa DV; Quy HT; Chau NV; Duy PM; Tho DQ; Chinh NT; Farrar JJ; Caws M
    Int J Tuberc Lung Dis; 2008 Jul; 12(7):736-42. PubMed ID: 18544197
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro susceptibility testing of levofloxacin and ofloxacin by microtiter plate Alamar blue against multidrug and non multidrug resistant Mycobacterium tuberculosis in Thailand.
    Pracharktam R; Angkananukool K; Vibhagool A
    J Med Assoc Thai; 2001 Sep; 84(9):1241-5. PubMed ID: 11800295
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increasing incidence of fluoroquinolone-resistant Mycobacterium tuberculosis in Mumbai, India.
    Agrawal D; Udwadia ZF; Rodriguez C; Mehta A
    Int J Tuberc Lung Dis; 2009 Jan; 13(1):79-83. PubMed ID: 19105883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Increased resistance to ciprofloxacin and ofloxacin in multidrug-resistant mycobacterium tuberculosis isolates from patients seen at a tertiary hospital in the Philippines.
    Grimaldo ER; Tupasi TE; Rivera AB; Quelapio MI; Cardaño RC; Derilo JO; Belen VA
    Int J Tuberc Lung Dis; 2001 Jun; 5(6):546-50. PubMed ID: 11409582
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low rate of fluoroquinolone resistance in Mycobacterium tuberculosis isolates from northern Tanzania.
    van den Boogaard J; Semvua HH; van Ingen J; Mwaigwisya S; van der Laan T; van Soolingen D; Kibiki GS; Boeree MJ; Aarnoutse RE
    J Antimicrob Chemother; 2011 Aug; 66(8):1810-4. PubMed ID: 21642290
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Baseline resistance and cross-resistance among fluoroquinolones in multidrug-resistant Mycobacterium tuberculosis isolates at a national reference laboratory in India.
    Mamatha HG; Shanthi V
    J Glob Antimicrob Resist; 2018 Mar; 12():5-10. PubMed ID: 28887289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Drug-resistant tuberculosis in Cuba. Results of the three global projects.
    Montoro E; Lemus D; Echemendía M; Armas L; González-Ochoa E; Llanes MJ; Valdivia JA
    Tuberculosis (Edinb); 2006; 86(3-4):319-23. PubMed ID: 16569512
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genotypic and phenotypic characterization of Mycobacterium tuberculosis resistance against fluoroquinolones in the northeast of Iran.
    Sayadi M; Zare H; Jamedar SA; Hashemy SI; Meshkat Z; Soleimanpour S; Hoffner S; Ghazvini K
    BMC Infect Dis; 2020 Jun; 20(1):390. PubMed ID: 32487030
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pulmonary resection combined with isoniazid- and rifampin-based drug therapy for patients with multidrug-resistant and extensively drug-resistant tuberculosis.
    Park SK; Kim JH; Kang H; Cho JS; Smego RA
    Int J Infect Dis; 2009 Mar; 13(2):170-5. PubMed ID: 18768342
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of extensive drug resistance on treatment outcomes in non-HIV-infected patients with multidrug-resistant tuberculosis.
    Kim HR; Hwang SS; Kim HJ; Lee SM; Yoo CG; Kim YW; Han SK; Shim YS; Yim JJ
    Clin Infect Dis; 2007 Nov; 45(10):1290-5. PubMed ID: 17968823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.